| Status | Awaiting development |
| Technology type | Medicine |
| Decision | None selected |
| Process | STA Standard |
| ID number | 3894 |
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 24 March 2021 | Please note that following on from advice received from the company this appraisal will be rescheduled to align with latest regulatory expectations. Further information regarding the timelines for this appraisal will be available in due course. |
For further information on our processes and methods, please see our CHTE processes and methods manual